Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehr
Storys zum Thema Gesundheit / Medizin
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
LTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
mehrBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
mehrSHL Medical partners with SteriPack Group to set up final assembly service
mehrLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
mehrLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
mehrSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
mehrBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
mehrSuperVista AG expands strategically with new 360-degree B2B offering for the entire ophthalmic optics sector
mehrSHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
mehrOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developments
mehrGerman Bionic Debuts Groundbreaking Power Suit for Nursing and Care Professionals in North America
mehrRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehrThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrBlood Donation Day at R-Biopharm: Employees Help Save Lives
mehrBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
mehrFlu tests from R-Biopharm also detect new virus variants
mehrStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
mehrMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalks
mehrKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
mehrR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
mehrR-Biopharm is IVDR certified
mehr- 2
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
mehr R-Biopharm announces test to detect monkeypox virus
mehr- 2
World's first electronic respirator sterilising (corona)-viruses of all variants completely by UV-LED-radiation-effected RNA destruction
mehr - 2
Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomats
mehr COVID-19 Testing Without Having to Wait in line: A German Startup Shows How it Works
mehr- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
mehr CHRISTMAS COMES EARLY FOR CHILDREN WITH CANCER COURTESY OF PM-INTERNATIONAL MALAYSIA
mehrArtificial intelligence in the healthcare sector: Lindera successfully closes financing round of six million euros
mehr
Vorherige1234Nächste